Researchers on Wednesday reported the largest-ever one-year decline in the US cancer death rate, a drop they credited to advances in lung-tumour treatments.
The overall cancer death rate has been falling about 1.5 per cent a year since 1991.
It fell 2.2 per cent from 2016 to 2017, according to the new American Cancer Society report.
That's the largest drop ever seen in national cancer statistics going back to 1930, said Rebecca Siegel, the lead author.
It's absolutely driven by lung cancer, which accounts for about a quarter of all cancer deaths, she said. Take lung cancer out of the mix, and the 2017 rate drop is 1.4 per cent, she added.
Government researchers previously reported a slightly lower drop in the cancer death rate for the same period.
But the Cancer Society calculates the death rate differently, and on Wednesday said the decline was larger and record-setting.
Most lung cancer cases are tied to smoking, and decades of declining smoking rates led to falling rates of lung cancer illnesses and deaths.
But the drop in deaths seems to have been accelerated by recent lung cancer treatment advances, Siegel said.
Experts mainly credit advances in treatment.
Topping the list are refinements in surgery, better diagnostic scanning, and more precise use of radiation.
They also celebrate the impact of newer drugs.
Genetic testing can now identify specific cancer cell mutations, which allow more targeted therapy using newer pharmaceuticals that are a step beyond traditional chemotherapy.
It's an exciting time, said Dr Jyoti Patel, a Northwestern University lung cancer expert.
Even patients with late-stage cancers are surviving for several years rather than months after treatment starts, she said.
That was very, very uncommon a decade ago, she said.
New immunotherapy drugs could accelerate the death rate decline, Patel said.
Cancer Society researchers also found:
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
